An expanding body of knowledge underlying the molecular pathogenesis of the disease has revealed that genetic alterations, such as KRAS mutations, and especially epigenetic abnormalities, are hallmarks of pancreatic tumors [4,47]. This evidence concerns the gene KRAS and pancreatic neoplasm.